Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Aug 15;11:1205–1217. doi: 10.2147/IDR.S171236

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Tsai et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Kaplan–Meier survival curve for patients treated with teicoplanin for MRSA bacteremia.

Notes: Cases are grouped according to treatment with teicoplanin maintenance dose ST or HI group) and further stratified by teicoplanin MICs. A log-rank test was used to compare the 2 survival curves. The results are indicated as 2-tailed p-values, with p<0.05 being statistically significant. Group 1: ST, teicoplanin MICs <1.5 mg/L for MRSA isolates (n=53); Group 2: ST, teicoplanin MICs ≥1.5 mg/L for MRSA isolates (n=49); Group 3: HI, teicoplanin MICs <1.5 mg/L for MRSA isolates (n=23); and Group 4: HI, teicoplanin MICs ≥1.5 mg/L for MRSA isolates (n=21).

Abbreviations: HI, high-dose regimen group; MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus; ST, standard-dose regimen group.